A Six Month, Open-label Outpatient, Parallel Group Trial Assessing The Impact Of Inhaled Insulin (Exubera(Registered)) On Glycemic Control In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On Two Oral Anti-diabetic Agents
A Six Month, Open-label Outpatient, Parallel Group Trial Assessing The Impact Of Inhaled Insulin (Exubera(Registered)) On Glycemic Control In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On Two Oral Anti-diabetic Agents
To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents
Inclusion Criteria:
Exclusion Criteria:
Chicoutimi, Quebec G7H 5H6, Canada
Saint-Foy, Quebec G1V 4G5, Canada
Nantes, Cedex 01 F-44035, France
Cean Cedex, 14033, France
Athens, 11527, Greece
Haidari, 124 62, Greece
Pireaus, 18454, Greece
Thessaloniki, 546 36, Greece
Istanbul, 34390, Turkey (Türkiye)